Guardant Health, Inc. (GH): Price and Financial Metrics

Guardant Health, Inc. (GH): $31.57

0.53 (+1.71%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

GH Price/Volume Stats

Current price $31.57 52-week high $38.53
Prev. close $31.04 52-week low $15.81
Day low $30.88 Volume 509,200
Day high $31.85 Avg. volume 2,025,384
50-day MA $29.25 Dividend yield N/A
200-day MA $25.93 Market Cap 3.90B

GH Stock Price Chart Interactive Chart >


Guardant Health, Inc. (GH) Company Bio


Guardant Health, Inc., a precision oncology company, provides non-invasive cancer diagnostics. It offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes from circulating tumor DNA (ctDNA); and GuardantOMNI, a broader panel measuring various genes from ctDNA. The company also provides LUNAR-1 for recurrence detection in cancer survivors; and LUNAR-2 for early detection of cancer in higher risk individuals. Guardant Health, Inc. was founded in 2011 and is based in Redwood City, California.


GH Latest News Stream


Event/Time News Detail
Loading, please wait...

GH Latest Social Stream


Loading social stream, please wait...

View Full GH Social Stream

GH Price Returns

1-mo -3.31%
3-mo 41.57%
6-mo 8.67%
1-year N/A
3-year N/A
5-year -61.48%
YTD 16.71%
2023 -0.55%
2022 -72.81%
2021 -22.39%
2020 64.93%
2019 107.87%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!